Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Debt to Equity (2022 - 2026)

HeartSciences (HSCS) has disclosed Debt to Equity for 3 consecutive years, with $0.01 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Debt to Equity changed N/A year-over-year to $0.01, compared with a TTM value of $0.01 through Oct 2024, changed N/A, and an annual FY2023 reading of $2.17, up 395.67% over the prior year.
  • Debt to Equity was $0.01 for Q4 2024 at HeartSciences, down from $0.08 in the prior quarter.
  • Across five years, Debt to Equity topped out at $2.17 in Q2 2023 and bottomed at -$3.88 in Q1 2023.
  • Average Debt to Equity over 3 years is -$0.42, with a median of $0.01 recorded in 2024.
  • Peak annual rise in Debt to Equity hit 395.67% in 2023, while the deepest fall reached 377.78% in 2023.
  • Year by year, Debt to Equity stood at $0.35 in 2022, then tumbled by 377.78% to -$0.96 in 2023, then skyrocketed by 101.28% to $0.01 in 2024.
  • Business Quant data shows Debt to Equity for HSCS at $0.01 in Q4 2024, $0.08 in Q3 2024, and -$0.96 in Q3 2023.